Concepedia

Eric Southam

ES

Statistics

Publications

34

Citations

4.4K

H-Index

27

Active since

1987

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

University of Liverpool

Wellcome Trust

University of Oxford

University College London

Eric Southam is an author at GlaxoSmithKline (United Kingdom) specializing in neuroscience, life sciences, and neurobiology.

ORCID

Publications per year

1987–2019

34

Publications

34

Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.

John Garthwaite, Eric Southam, Caroline L. Boulton et al. · Molecular Pharmacology · 1995 · 1.1K citations

, , +15

The nitric oxide-cyclic GMP signalling pathway in rat brain

Eric Southam, John Garthwaite · Neuropharmacology · 1993 · 354 citations

, , +14

GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models

Andrew D. Medhurst, A.R. Atkins, I.J.M. Beresford et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 301 citations

, , +13

Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase

Caroline L. Boulton, Eric Southam, John Garthwaite · Neuroscience · 1995 · 283 citations

, , +11

Excitatory Amino Acid Receptors Coupled to the Nitric Oxide/Cyclic GMP Pathway in Rat Cerebellum During Development

Eric Southam, Stephen J. East, John Garthwaite · Journal of Neurochemistry · 1991 · 239 citations

, , +17

1–5 of 34